Recurrence pattern analysis after [68Ga]-DOTATATE-PET/CT-planned radiotherapy of high-grade meningiomas

被引:19
|
作者
Zollner, Barbara [1 ]
Ganswindt, Ute [1 ]
Maihoefer, Cornelius [1 ]
Corradini, Stefanie [1 ]
Albert, Nathalie Lisa [2 ]
Schichor, Christian [3 ]
Belka, Claus [1 ,4 ,5 ]
Niyazi, Maximilian [1 ,4 ,5 ]
机构
[1] Ludwig Maximilians Univ Munchen, Univ Hosp, Dept Radiat Oncol, Marchioninistr 15, D-81377 Munich, Germany
[2] Ludwig Maximilians Univ Munchen, Univ Hosp, Dept Nucl Med, Marchioninistr 15, D-81377 Munich, Germany
[3] Ludwig Maximilians Univ Munchen, Univ Hosp, Dept Neurosurg, Marchioninistr 15, D-81377 Munich, Germany
[4] German Canc Consortium DKTK, Partner Site Munich, Munich, Germany
[5] German Canc Res Ctr, Heidelberg, Germany
来源
RADIATION ONCOLOGY | 2018年 / 13卷
关键词
Atypical and anaplastic meningioma; Radiotherapy; Recurrence pattern; Safety margin; IMRT; STEREOTACTIC RADIOTHERAPY; ANAPLASTIC MENINGIOMAS; ADJUVANT RADIOTHERAPY; PROTON THERAPY; DIAGNOSIS; SURVIVAL; FAILURE; CLASSIFICATION; IRRADIATION; TUMORS;
D O I
10.1186/s13014-018-1056-4
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: The aim of the present study was to evaluate the influence of the applied safety margins of modern intensity-modulated radiotherapy (IMRT) in patients with high-grade meningiomas on local control and recurrence patterns. Methods: Twenty patients with a neuropathological diagnosis of a high-grade meningioma (WHO degrees II or degrees III) treated with adjuvant or definitive radiotherapy between 2010 and 2015 were included in the present retrospective analysis. All patients were planned PET-based. Recurrence patterns were assessed by means of MRI and/or DOTATATE-PET/computertomography (CT). Results: The median follow-up was 31.0 months [95% confidence interval (CI): 20.1-42.0] and the progressionfree survival (PFS) after 24 months was 87.5%. Overall, four patients had a local recurrence of their meningioma. Of these, three were located in field according to the prior radiotherapy treatment region, while only one patient had a distant relapse. There were no independent factors influencing progression-free or overall survival (OS). Conclusion: After radiotherapy (RT), patients with atypical or anaplastic meningiomas still have a defined risk of tumor recurrence. The aim of the present study was to examine mono-institutional data concerning target volume definition and recurrence patterns after radiotherapy of high-grade meningiomas as there are limited data available. Our data suggest that extended safety margins are necessary to achieve a favorable local control for high-grade meningiomas.
引用
收藏
页数:9
相关论文
共 50 条
  • [1] Recurrence pattern analysis after [68Ga]-DOTATATE-PET/CT -planned radiotherapy of high-grade meningiomas
    Barbara Zollner
    Ute Ganswindt
    Cornelius Maihöfer
    Stefanie Corradini
    Nathalie Lisa Albert
    Christian Schichor
    Claus Belka
    Maximilian Niyazi
    Radiation Oncology, 13
  • [2] Influence of [68Ga]-DOTATATE-PET/CT on Target Volume Definition in Low-Grade Skull Base Meningiomas
    Fuchs, Frederik
    Hofmaier, Jan
    Marschner, Sebastian Norbert
    Rottler, Maya
    Bodensohn, Raphael
    Belka, Claus
    Niyazi, Maximilian
    Walter, Franziska
    RADIOTHERAPY AND ONCOLOGY, 2024, 194 : S870 - S871
  • [3] Impact of [68Ga]-DOTATATE-PET/CT on Target Volume Definition in low-grade Meningiomas of the Cranial Base
    Walter, F.
    Hofmaier, J.
    Hadi, I
    Rottler, M.
    Steffens, R.
    Zollner, B.
    Vettermann, F.
    Belka, C.
    Niyazi, M.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2020, 196 (SUPPL 1) : S125 - S125
  • [4] [68GA]-DOTATATE-PET IMAGING PREDICTS SOMATOSTATIN RECEPTOR II EXPRESSION IN MENINGIOMAS
    Rachinger, W.
    Stoecklein, V.
    Haug, A. R.
    Schueller, U.
    Schichor, C.
    Thon, N.
    Tonn, J. C.
    NEURO-ONCOLOGY, 2014, 16
  • [5] Recurrence Pattern Analysis after Irradiation of high-grade Meningiomas
    Zollner, B. D.
    Ganswindt, U.
    Maihoefer, C.
    Albert, N. L.
    Belka, C.
    Niyazi, M.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2017, 193 : S161 - S161
  • [6] Ga-68 DOTATATE PET/CT imaging for robotic radiotherapy in patients with meningiomas
    Fudzinska, M.
    Tarnawski, R.
    Nowicka, E.
    Grzbiela, H.
    Gawkowska-Suwinska, M.
    D'Amico, A.
    Binczyk, F.
    Matulewicz, L.
    RADIOTHERAPY AND ONCOLOGY, 2015, 115 : II - II
  • [7] [68Ga]DOTATATE-PET-based Target Volume Definition in Meningiomas WHO Grade I
    Zollner, B. D.
    Vettermann, F.
    Ilhan, H.
    Albert, N. L.
    Ganswindt, U.
    Belka, C.
    Niyazi, M.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2017, 193 : S152 - S152
  • [8] Head to Head Comparison of [68Ga]Ga-FAPI-04 and [68Ga]Ga-DOTATATE PET/CT in Patients With Recurrence Medullary Thyroid Carcinoma
    Isik, E.
    Civan, C.
    Simsek, D. Has
    Ozkan, Z. G.
    Gul, N.
    Erturk, S. M.
    Sanli, Y.
    Kuyumcu, S.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2022, 49 (SUPPL 1) : S508 - S508
  • [9] Meningioma Revisited: Should Whole-Body Staging with [68Ga]Ga-DOTATOC PET/CT of High-Grade Meningiomas Become Standard Practice?
    Ermis, Ekin
    Bachmann, Nicolas
    Lutz, Katharina
    Pyka, Thomas
    JOURNAL OF NUCLEAR MEDICINE, 2025, 66 (01) : 162 - 162
  • [10] PRELIMINARY ANALYSIS OF REPRODUCIBILITY OF [68Ga]DOTATATE PET/CT IMAGING of NEUROENDOCRINE TUMOURS (NETs)
    Bailey, Dale
    Gholami, Yaser
    James, Angela
    Chan, David
    Bernard, Elizabeth
    JOURNAL OF NUCLEAR MEDICINE, 2022, 63